Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nathan P. Lavey"'
Autor:
Jimmy D. Ballard, Adam S Duerfeldt, Tyler M. Shadid, Catherine E Bishop, Megan L. Kempher, Nathan P. Lavey
Publikováno v:
J Bacteriol
The Gram-positive bacterium Clostridioides difficile is a primary cause of hospital-acquired diarrhea, threatening both immunocompromised and healthy individuals. An important aspect of defining mechanisms that drive C. difficile persistence and viru
Autor:
Adam S. Duerfeldt, Jimmy D. Ballard, Bishop Ce, Tyler M. Shadid, Nathan P. Lavey, Nagib Ahsan, Megan L. Kempher
The Gram-positive bacterium Clostridioides difficile is a primary cause of hospital-acquired diarrhea, threatening both immunocompromised and healthy individuals. An important aspect of elucidating mechanisms that drive C. difficile persistence and v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a32a074964ca2f525095c02fe32f81e2
https://doi.org/10.1101/2021.02.05.429978
https://doi.org/10.1101/2021.02.05.429978
Publikováno v:
ACS Infectious Diseases. 5:79-89
Caseinolytic protease P (ClpP) has emerged as a promising new target for antibacterial development. While ClpPs from single isoform expressing bacteria have been studied in detail, the function and regulation of systems with more than one ClpP homolo
Autor:
Jessica E. Knobbe, Yu-Shan Lin, Jesse A. Coker, Yangxiong Li, Adam S. Duerfeldt, Hongtao Yu, Susan L. Nimmo, Dat C. Truong, Nathan P. Lavey
Publikováno v:
ACS medicinal chemistry letters. 8(11)
The acyldepsipeptide (ADEP) antibiotics operate through a clinically unexploited mechanism of action and thus have attracted attention from several antibacterial development groups. The ADEP scaffold is synthetically tractable, and deep-seated modifi
Publikováno v:
Journal of natural products. 79(4)
Caseinolytic protease P (ClpP) maintains essential roles in bacterial homeostasis. As such, both the inhibition and activation of this enzyme result in bactericidal activity, making ClpP a promising target for antibacterial drug development. Herein,